Literature DB >> 10364009

Does progesterone fluctuation across the menstrual cycle predispose to gastroesophageal reflux?

A Alvarez-Sánchez1, E Rey, S R Achem, M Díaz-Rubio.   

Abstract

OBJECTIVE: Gastroesophageal reflux (GER) occurs in 30-50% of all pregnancies. The progressive rise in plasma progesterone has been suggested as a possible mediator of GER during pregnancy. It is not known whether progesterone, at physiological concentrations, has an effect on acid contact time. We sought to evaluate the relationship between progesterone concentrations, lower esophageal sphincter pressure (LESP), and acid contact time across the normal menstrual cycle.
METHODS: LESP, 24-h ambulatory esophageal pH monitoring, and serum progesterone levels were determined in 19 healthy women known to have normal menstrual cycles. All tests were performed during the follicular phase (days 2-7) and the luteal phase (days 22-28) of one or two consecutive menstrual cycles.
RESULTS: Despite marked oscillations in progesterone levels between the follicular phase (0.37 +/- 0.3 ng/ml) and luteal phase (4.64 +/- 2.92 ng/ml) we observed no significant differences in LESP (29.82 +/- 9.49 vs 30.45 +/- 8.56 mm Hg) or 24-h ambulatory pH levels (pH < 4) in total time (3.04 +/- 0.3% vs 3.18 +/- 2.51%), upright time (4.41 +/- 3.54% vs 4.18 +/- 3.36%), or supine time (0.77 +/- 1.32% vs 1.42 +/- 2.18%).
CONCLUSIONS: The fluctuations in progesterone levels across the normal menstrual cycle have no significant impact on LESP and 24-h ambulatory pH parameters. Progesterone, at physiological concentrations, does not predispose to GER in healthy menstruating women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364009     DOI: 10.1111/j.1572-0241.1999.01128.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  In vitro fertilization-induced pregnancies predispose to gastroesophageal reflux disease.

Authors:  Ilker Turan; Gul Kitapcioglu; Ege Tavmergen Goker; Gulnaz Sahin; Serhat Bor
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

Review 2.  Impact of changing epidemiology of gastroesophageal reflux disease on its diagnosis and treatment.

Authors:  Hugo Bonatti; Sami R Achem; Ronald A Hinder
Journal:  J Gastrointest Surg       Date:  2008-02       Impact factor: 3.452

3.  Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study.

Authors:  Helen Close; James M Mason; Douglas Wilson; A Pali S Hungin
Journal:  BMC Gastroenterol       Date:  2012-05-29       Impact factor: 3.067

4.  First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease.

Authors:  Chih-Ming Liang; Ming-Te Kuo; Pin-I Hsu; Chao-Hung Kuo; Wei-Chen Tai; Shih-Cheng Yang; Keng-Liang Wu; Hsing-Ming Wang; Chih-Chien Yao; Cheng-En Tsai; Yao-Kuang Wang; Jiunn-Wei Wang; Chih-Fang Huang; Deng-Chyang Wu; Seng-Kee Chuah
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.